Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.
Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.
复制标题
丙酮酸乙酯可防止血脑屏障损伤并改善创伤性脑损伤大鼠模型的长期神经学结果。
DOI:
10.1111/cns.12366
复制
发表时间:
2015-04
影响因子:
5.5
通讯作者:
Gao YQ
中科院分区:
文献类型:
--
作者:
Shi H;Wang HL;Pu HJ;Shi YJ;Zhang J;Zhang WT;Wang GH;Hu XM;Leak RK;Chen J;Gao YQ
Many traumatic brain injury (TBI) survivors sustain neurological disability and cognitive impairments due to the lack of defined therapies to reduce TBI-induced long-term brain damage. Ethyl pyruvate (EP) has shown neuroprotection in several models of acute brain injury. The present study therefore investigated the potential beneficial effect of EP on long-term outcomes after TBI and the underlying mechanisms. Male adult rats were subjected to unilateral controlled cortical impact injury. EP was injected intraperitoneally 15 min after TBI and again at 12, 24, 36, 48, and 60 h after TBI. Neurological deficits, blood-brain barrier (BBB) integrity and neuroinflammation were assessed. EP improved sensorimotor and cognitive functions and ameliorated brain tissue damage up to 28 d post-TBI. BBB breach and brain edema were attenuated by EP at 48 h after TBI. EP suppressed matrix metalloproteinase (MMP)-9 production from peripheral neutrophils and reduced the number of MMP-9-overproducing neutrophils in the spleen, and therefore mitigated MMP-9-mediated BBB breakdown. Moreover, EP exerted potent anti-inflammatory effects in cultured microglia and inhibited the elevation of inflammatory mediators in the brain after TBI. EP confers long-term neuroprotection against TBI, possibly through breaking the vicious cycle among MMP-9-mediated BBB disruption, neuroinflammation and long-lasting brain damage.
登录
查看更多内容
DOI:
10.1165/rcmb.2007-0330oc
发表时间:
2008-10-01
影响因子:
6.4
作者:
Hamada, Naoki;Maeyama, Takashige;Nakanishi, Yoichi
通讯作者:
Nakanishi, Yoichi
影响因子:
11.2
作者:
Ramlackhansingh, Anil F.;Brooks, David J.;Sharp, David J.
通讯作者:
Sharp, David J.
影响因子:
4.2
作者:
AIHARA, N;HALL, JJ;NOBLE, LJ
通讯作者:
NOBLE, LJ
影响因子:
3
作者:
Metz, GA;Whishaw, IQ
通讯作者:
Whishaw, IQ
DOI:
10.2174/1871527311312030006
发表时间:
2013-05-01
期刊:
CNS & neurological disorders drug targets
影响因子:
--
作者:
Leak RK;Zhang L;Stetler RA;Weng Z;Li P;Atkins GB;Gao Y;Chen J
通讯作者:
Chen J